期刊文献+

局部进展期直肠癌术前新辅助治疗后凋亡相关蛋白检测及临床意义 被引量:9

Detection and clinical significance of apoptosis related protein in local advanced rectal cancer patients with preoperative neoadjuvant therapy
原文传递
导出
摘要 目的通过局部进展期直肠癌患者术前同步放化疗前、后的凋亡相关蛋白的检测,探讨放化疗诱导直肠癌凋亡的机制并评价其疗效。方法应用免疫组化EnVision法检测术前同步放化疗前、后Bcl—XL、Bax表达,结合患者临床、病理各项指标,进行统计学分析和评价。结果术前同步放化疗后肿瘤细胞退缩明显(TRG2+TRG3+TRG4)患者13例,无退缩(TRGO+TRGl)患者21例,术前同步放化疗前、后Bcl—XL阳性率分别为58.8%(20/34)和52.9%(18/34),放化疗前、后Bcl-XL表达变化与放化疗前肿瘤大小,放疔后肿瘤细胞退缩以及手术方式之间差异有统计学意义。术前同步放化疗前、后Bax阳性率分别为32.4%(11/34)和44.1%(15/34),Bax表达变化与放疗后肿瘤细胞退缩间差异无统计学意义。术前同步放化疗前、后Bcl—XL/Bax比值之间差异有统计学意义(χ^2=9.607,P=0.048)。术前同步放化疗前、后Bcl—XL/MBax比值与肿瘤细胞退缩之间差异无统计学意义。按照术前同步放化疗是否加热疗进行分层分析,发现单纯放化疗组Bcl—XL表达变化与手术方式之间差异有统计学意义(χ^2=13.964,P=0.007),单纯放化疗组Bax表达变化与肿瘤肌层浸润和放疗后肿瘤细胞退缩之间差异有显著性意义(χ^2=10.806、10.455,P〈0.05)。结论术前同步放化疗可以改变Bcl—XL、Bax表达,影响直肠癌细胞凋亡和患者治疗效果,Bcl—XL表达减低和Bax表达上调在术前同步放化疗诱导直肠癌细胞凋亡中具有重要的临床作用,可有效提高直肠癌放化疗的效果。 Objective To discuss the mechanism of rectal cancer apoptosis induced by preoperative chemoradiotherapy and evaluate its effect by detection of apoptosis related proteins in locally advanced colorectal cancer patients who had received preoperative chemoradiation. Methods To detect Bcl-XL and Bax expression in rectal cancer before and after chemoradiotherapy by EnVision method, combined with patients clinical and pathological index, statistically analysis and evaluation their relationship and clinical significance. Results Patients with or without tumor shrinkage after preoperative cbemoradiotherapy was 13 cases and 21 cases. While the positive rate of Bcl-XL in rectal cancer before and after chemoradiotherapy were 58.8% ( 20/34 ) and 52. 9% ( 18/34 ) , respectively. There were significant difference between Bcl-XL change before and after chemoradiation with tumor size, tumor cells shrinkage and operation pattern. The positive rate of Bax in rectal cancer before and after chemoradiotherapy were 32.4% (11/34) and 44. 1% (15/34) , respectively. There were no significant difference between Bax change before and after chemoradiotherapy with tumor cells shrinkage. There were statistically significant difference between Bax ratio (χ^2 = 9. 607, P = 0. 048 ) before and after chemoradiation while there were no significant difference between Bcl-XL/Bax ratio before and after chemoradiation with tumor shrinkage. According to layeredanalysis with preoperative therapy, there were statistically significant difference (χ^2 ~ 13. 964, P = 0. 007 ) between Bcl-XL change with operation pattern while the same of significant differenee between Bax ehange with tumor infihration and tumor shrinkage ( χ^2 = 10. 806 and 10. 455, both P 〈 0. 05 ). Conclusions Preoperative chemoradiation can influence rectal cancer eell's apoptosis and treatment effect by changing Bel- XL and Bax expression. Bcl-XL downregulation and Bax upregulation have shown important function in colorectal cancer cell apoptosis which induced by preoperative chemoradiation, it can also improve the effection of ehemoradiation in rectal eaneer.
出处 《中华外科杂志》 CAS CSCD 北大核心 2012年第10期914-917,共4页 Chinese Journal of Surgery
基金 基金项目:浙江省自然科学基金资助项目(Y2080634) 浙江省医药卫生科学研究基金资助项目(2008B021)
关键词 直肠肿瘤 化学疗法 辅助 放射疗法 辅助 Bcl-X蛋白质 Bcl-2相关蛋白质 细胞凋亡 Rectal neoplasms Chemotherapy, adjuvant Rediotherapy, adjuvant Bcl-Xprotein Bcl-2-associated X protein Apoptosis
  • 相关文献

参考文献11

  • 1Abdulamir AS, Hafidh RR, Abubakar F. Different inflammatory mechanisms in lungs of severe and mild asthma: crosstalk of NF- kappa-B, TGFbetal, Bax, Bcl-2, IL-4 and IgE. Scand J Clin Lab Invest, 2009, 69: 487-495.
  • 2Cory S, Huang DC, Adams JM. The Bcl-2 family: roles in cell survival and oncogenesis. Oncogene, 2003, 22: 8590-8607.
  • 3Meng XW, Lee SH, Kaufmann SH. Apoptosis in the treatment of cancer: a promise kept? Curr Opin Cell Biol, 2006, 18: 668- 676.
  • 4Zhang YL, Pang LQ, Wu Y, et al. Significance of Bcl-XL in human colon carcinoma. World J Gastroenterol, 2008, 14: 3069- 3073.
  • 5Muchmore SW, Sattler M, Liang H, et al. X-ray and NMR structure of human Bcl-XL, an inhibitor of programmed cell death. Nature, 1996, 381: 335-341.
  • 6Sattler M, Liang H, Nettesheim D, et al. Structure of Bcl-XL-Bak peptide complex: recognition between regulators of apoptosis. Science, 1997, 275: 983-986.
  • 7Gallenne T, Gautier F, Oliver L, et al. Bax activation by the BH3-only protein Puma promotes cell dependence on antiapoptotic Bcl-2 family members. J Cell Biol, 2009, 185: 279-290.
  • 8Yang WL, Addona T, Nair DG, et al. Apoptosis induced by cryo- injury in human colorectal cancer cells is associated with mitochondrial dysfunction. Int J Cancer, 2003, 103: 360-369.
  • 9Paradiso A, Simone G, Lena MD, et al. Expression of apoptosis- related markers and clinical outcome in patients with advanced colorectal cancer. Br J Cancer, 2001, 84: 651-658.
  • 10Shimizu S, Eguchi Y, Kosaka H, et al. Prevention of hypoxia- induced cell death by Bcl-2 and Bcl-XL. Nature, 1995, 374: 811-813.

同被引文献112

  • 1欧阳淼,张桂英,徐美华.大肠黏膜癌变过程中PGE_2,Bcl-2及Bax表达相关性[J].世界华人消化杂志,2005,13(11):1305-1309. 被引量:6
  • 2李玉莉,胡静姿,刘惠敏,余宏宇,何金,朱维健.Bcl-2、Bcl-xL和Bax蛋白在结直肠癌中的表达[J].癌变.畸变.突变,2007,19(1):53-55. 被引量:6
  • 3Sebag-Montefiore D, Stephens RJ, Steele R, et al. Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016) :a multicentre, randomised trial[ J]. Lancet, 2009, 373:811-20.
  • 4Andr6 T, Boni C,Navarro M, et al. Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treat- ment in stage II or III colon cancer in the MOSAIC trial [ J ]. J Clin Oncol, 2009, 27:3109-3116.
  • 5de Bruin AF, Gosselink MP, Wijffels NA, et al. Local genta- micin reduces perineal wound iufection after radiotherapy and abdominoperineal resection[ J]. Tech Coloproctol, 2008, 12 : 303-307.
  • 6Jemal A,Center MM,DeSantis C,et at.Global patterns of cancer incidence and mortality rates and trends[J].Cancer Epidemiol Biomarkers Prey,2010,19(8):1893-1907.
  • 7Yang SY,Sales KM,Fuller B,et al.Apoptosis and colorectal cancer:implications for therapy[J].Trends Mol Med,2009,15 (5):225.
  • 8Hanahan D,Weinberg RA.The hallmarks of cancer[J].Cell,2000,100(1):57-70.
  • 9Jansson A,Sun XF.Bax expression decreases significantly from primary tumor to metastasis in colorectal cancer[J].J Clin Onco1,2002,20(3):811-816.
  • 10Ogura E,Senzaki H,Yamamoto D,et al.Prognostic significance of Bcl-2,Bcl-xL/S,Bax and Bak expressions in colorectal carcinomas[J].Oncol Rep,1999,6 (2):365-369.

引证文献9

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部